Clinical Management of Primary Biliary Cholangitis—Strategies and Evolving Trends
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Immunology and Allergy
Link
http://link.springer.com/content/pdf/10.1007/s12016-019-08772-7.pdf
Reference149 articles.
1. European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L (2017) EASL clinical practice guidelines: the diagnosis and management of patients with primary biliary cholangitis. J Hepatol 67(1):145–172. https://doi.org/10.1016/j.jhep.2017.03.022
2. Li Y, Tang R, Leung PSC, Gershwin ME, Ma X (2017) Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases. Autoimmun Rev 16(9):885–896. https://doi.org/10.1016/j.autrev.2017.07.002
3. Hirschfield GM, Dyson JK, Alexander GJM, Chapman MH, Collier J, Hubscher S, Patanwala I, Pereira SP, Thain C, Thorburn D, Tiniakos D, Walmsley M, Webster G, Jones DEJ (2018) The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut 67(9):1568–1594. https://doi.org/10.1136/gutjnl-2017-315259
4. Kowdley KV, Luketic V, Chapman R, Hirschfield GM, Poupon R, Schramm C, Vincent C, Rust C, Pares A, Mason A, Marschall HU, Shapiro D, Adorini L, Sciacca C, Beecher-Jones T, Bohm O, Pencek R, Jones D, Obeticholic Acid PBCMSG (2018) A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis. Hepatology 67(5):1890–1902. https://doi.org/10.1002/hep.29569
5. Lazaridis KN, Gores GJ, Lindor KD (2001) Ursodeoxycholic acid ‘mechanisms of action and clinical use in hepatobiliary disorders’. J Hepatol 35(1):134–146
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of PXR agonists from Hypericum japonicum: A class of novel nonaromatic acylphloroglucinol-terpenoid adducts;Bioorganic Chemistry;2024-06
2. Progress in the Management of Patients with Cholestatic Liver Disease: Where Are We and Where Are We Going?;Journal of Clinical and Translational Hepatology;2024-05-11
3. Unveiling the Role of CD27+ Memory B Cells in Primary Biliary Cholangitis: A Mendelian Randomization Study;2024-01-08
4. Nanomedicine-Mediated Drug Delivery for Potential Treatment of Inflammatory Bowel Disease: A Narrative Review;Nanomedicine;2024-01
5. Liver-Targeting Nanoplatforms for the Induction of Immune Tolerance;Nanomaterials;2023-12-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3